---
$id: https://graph.org.ai/products/commodity/51151517
$type: Product
source: UNSPSC
code: "51151517"
title: "Cevimeline"
class: "51151500"
classTitle: "Cholinergic drugs and cholinesterase inhibitors"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cevimeline

**UNSPSC Code**: 51151517
**Class**: [Cholinergic drugs and cholinesterase inhibitors](Cholinergic drugs and cholinesterase inhibitors.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cholinergic agonist with the molecular formula C10H17NOS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K9V0CDQ56E, chemically known as 2-methyspiro(1,3-oxathiolane-5,3)quinuclidine but generally known as cevimeline, which bears US NIH Compound Identifier 83898. European Medicines Agency schedules Cevimeline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07461MIG. The term CEVIMELINE is an International Non-Proprietary Name. World Health Organization schedules cevimeline in its Anatomical Therapeutic Chemical (ATC) Classification. CEVIMELINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cevimeline under HS 29349990 and SITC 51579. As of Q4 2014, CEVIMELINE remains the US FDA Preferred Term for this commodity. Cevimeline bears US NLM identifiers UMLS ID C0093437 and NCI Concept Code C66873. SMILES: CC1OC2(CN3CCC2CC3)CS1.

